Journal of Tissue Engineering and Regenerative Medicine
Leading citation impact metric from Clarivate Journal Citation Reports
59 papers with at least that number of citations each
State Council for Professorship (HĐGSNN) Scoring
Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)
HĐGSNN Score History
By article publication year| Year | Max Score | Evaluation Details | Source |
|---|---|---|---|
| 2026 | 1.50đ | WoS Q3(IF: 2) | 🔵 Computed |
| 2025 | 1.50đ | WoS Q3(IF: 2.6) | 🔵 Computed |
| 2024 | 1.50đ | WoS Q3(IF: 3.1) | 🔵 Computed |
| 2023 | 1.50đ | WoS Q3(IF: 3.3) | 🔵 Computed |
| 2022 | 1.50đ | WoS Q3(IF: 4.323) | 🔵 Computed |
| 2021 | 1.50đ | WoS Q3(IF: 3.963) | 🔵 Computed |
| 2020 | 1.50đ | WoS Q3(IF: 3.078) | 🔵 Computed |
| 2019 | 1.50đ | WoS Q3(IF: 3.319) | 🔵 Computed |
| 2018 | 1.50đ | WoS Q3(IF: 4.089) | 🔵 Computed |
Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.
Aims & Scope
Journal of Tissue Engineering and Regenerative Medicine publishes rapidly and rigorously peer-reviewed research papers, reviews, clinical case reports, perspectives, and short communications on topics relevant to the development of therapeutic approaches which combine stem or progenitor cells, biomaterials and scaffolds, growth factors and other bioactive agents, and their respective constructs. All papers should deal with research that has a direct or potential impact on the development of novel clinical approaches for the regeneration or repair of tissues and organs. The journal is multidisciplinary, covering the combination of the principles of life sciences and engineering in efforts to advance medicine and clinical strategies. The journal focuses on the use of cells, materials, and biochemical/mechanical factors in the development of biological functional substitutes that restore, maintain, or improve tissue or organ function. The journal publishes research on any tissue or organ and covers all key aspects of the field, including the development of new biomaterials and processing of scaffolds; the use of different types of cells (mainly stem and progenitor cells) and their culture in specific bioreactors; studies in relevant animal models; and clinical trials in human patients performed under strict regulatory and ethical frameworks. Manuscripts describing the use of advanced methods for the characterization of engineered tissues are also of special interest to the journal readership.
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Measures cumulative publication volume and citation impact.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
| Category | Index | Rank | Quartile |
|---|---|---|---|
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | JCRSCIE | 137/180 | Q4 |
CELL & TISSUE ENGINEERING | JCRSCIE | 27/32 | Q4 |
CELL BIOLOGY | JCRSCIE | 172/207 | Q4 |
ENGINEERING, BIOMEDICAL | JCRSCIE | 94/130 | Q3 |
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | JCISCIE | 121/180 | Q3 |
CELL & TISSUE ENGINEERING | JCISCIE | 22/32 | Q3 |
CELL BIOLOGY | JCISCIE | 142/207 | Q3 |
ENGINEERING, BIOMEDICAL | JCISCIE | 83/130 | Q3 |
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
| Year | Impact Factor | Articles / Year | Total Citations |
|---|---|---|---|
| 2026 | — | 5 | 0 |
| 2025 | 2.6 | 22 | 40 |
| 2024 | 3.1 | 13 | 58 |
| 2023 | 3.3 | 37 | 188 |
| 2022 | 4.323 | 101 | 1,255 |
| 2021 | 3.963 | 127 | 1,860 |
| 2020 | 3.078 | 168 | 2,734 |
| 2019 | 3.319 | 226 | 6,802 |
| 2018 | 4.089 | 183 | 4,271 |
| 2017 | — | 283 | 8,761 |
| 2016 | — | 237 | 5,388 |
| 2015 | — | 150 | 5,556 |
Journal Metrics & Citation Visualizations
Impact Factor Trend (2018–2024)
Clarivate IF trend for Journal of Tissue Engineering and Regenerative Medicine
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics